Impact Factor 3.520
2017 JCR, Clarivate Analytics 2018

Frontiers journals are at the top of citation and impact metrics

Review ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Cell. Infect. Microbiol. | doi: 10.3389/fcimb.2019.00138

Exploring the “multiple-hit hypothesis” of neurodegenerative disease: bacterial infection comes up to bat

  • 1College of Medicine, Texas A&M University, United States

Despite major strides in personalized genomics, it remains poorly understood why neurodegenerative diseases occur in only a fraction of individuals with a genetic predisposition and conversely, why individuals with no genetic risk of a disorder develop one. Chronic diseases like Alzheimer’s, Parkinson’s, and multiple sclerosis are speculated to result from a combination of genetic and environmental factors, a concept commonly referred to as the “multiple hit hypothesis”. A number of bacterial infections have been linked to increased risk of neurodegeneration, and in some cases, clearance of bacterial pathogens has been correlated with amelioration of CNS deficits. Additionally, mutations in several genes known to contribute to CNS disorders like Parkinson’s Disease have repeatedly been implicated in susceptibility to intracellular bacterial infection. Recent data has begun to demonstrate roles for these genes (Parkin, PINK1, and LRRK2) in modulating innate immune outcomes, suggesting that immune dysregulation may play an even more important role in neurodegeneration than previously appreciated. This review will broadly explore the connections between bacterial infection, immune dysregulation, and central nervous system (CNS) disorders. Understanding this interplay and how bacterial pathogenesis contributes to the “multiple-hit hypothesis” of neurodegeneration will be crucial to develop therapeutics to effectively treat both neurodegeneration and infection.

Keywords: Bacterial Pathogenesis, Parkinson's disease, neurodegenerative disease, Alzheimer's disease, Neuroinflammation, Parkin (PARK2), LRRK2, PINK1, Mycobacterium tuberculosis

Received: 01 Mar 2019; Accepted: 16 Apr 2019.

Edited by:

John S. Gunn, The Research Institute at Nationwide Children's Hospital, United States

Reviewed by:

Brian J. Balin, Philadelphia College of Osteopathic Medicine, United States
Robert W. Crawford, California State University, Sacramento, United States  

Copyright: © 2019 Patrick, Bell, Weindel and Watson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dr. Robert O. Watson, College of Medicine, Texas A&M University, Bryan, 77807, Texas, United States, robert.watson@medicine.tamhsc.edu